Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: The role of renal sympathetic innervation

American Journal of Hypertension

Volumn 28, Issue 2, 2015, Pages 256-265

  Linz, Dominik ^a   Hohl, Mathias ^a   Schütze, Jonathan ^a   Mahfoud, Felix ^a   Speer, Thimoteus ^a   Linz, Benedikt ^a   Hübschle, Thomas ^b   Juretschke, Hans Paul ^b   Dechend, Ralf ^c   Geisel, Jürgen ^a   Rütten, Hartmut ^b   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^c Experimental and Clinical Research Center   (Germany)

Author keywords

Blood pressure; heart injury; hypertension; metabolic syndrome; obese spontaneously hypertensive rats; renal dysfunction; renal sympathetic denervation

Indexed keywords

ALBUMIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; GADOLINIUM; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; SODIUM; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; TYROSINE 3 MONOOXYGENASE;

ALBUMINURIA; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC DYSFUNCTION; DISEASE COURSE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE REMODELING; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; KIDNEY DENERVATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY INNERVATION; KIDNEY PERFUSION; KOLETSKY RAT; MALE; MEAN ARTERIAL PRESSURE; METABOLIC PARAMETERS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SODIUM URINE LEVEL; SYMPATHETIC INNERVATION; TELEMETRY; UPREGULATION; ACUTE KIDNEY INJURY; ADRENERGIC SYSTEM; ANIMAL; BLOOD PRESSURE; COMPLICATION; HEART MUSCLE; HYPERTENSION; INNERVATION; KIDNEY; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; SYMPATHECTOMY;

ACUTE KIDNEY INJURY; ANIMALS; BLOOD PRESSURE; CREATININE; DISEASE PROGRESSION; HYPERTENSION; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; OBESITY; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR REMODELING;

EID: 84922568041     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu123     Document Type: Article

References (32)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Efect of potentially modifable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 1997; 364:937-952.
2. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:75-197.
3. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
4. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R, Mancia G. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 2011; 57:846-851.
5. Schlaich M P, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve fring, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 2004; 43:169-175.
6. Sobotka PA, Mahfoud F, Schlaich MP, Hoppe UC, Böhm M, Krum H. Sympatho-renal axis in chronic disease. Clin Res Cardiol 2011; 100:1049-1057.
7. Lambert G W, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Ter 2010; 126:159-172.
8. Böhm M, Linz D, Urban D, Mahfoud F, Ukena C. Renal sympathetic denervation: applications in hypertension and beyond. Nat Rev Cardiol 2013; 10:465-476.
9. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich M P. Substantial reduction in single sympathetic nerve fring afer renal denervation in patients with resistant hypertension. Hypertension 2013; 61:457-464.
10. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Tambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
11. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difcult-to-control hypertensive patients: prospective case series. Hypertension 2012; 60:1485-1490.
12. Katayama T, Sueta D, Kataoka K, Hasegawa Y, Koibuchi N, Toyama K, Uekawa K, Mingjie M, Nakagawa T, Maeda M, Ogawa H, Kim-Mitsuyama S. Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome. J Am Heart Assoc 2013; 2:e000197.
13. Nakagawa T, Hasegawa Y, Uekawa K, Ma M, Katayama T, Sueta D, Toyama K, Kataoka K, Koibuchi N, Maeda M, Kuratsu J, Kim-Mitsuyama S. Renal denervation prevents stroke and brain injury via attenuation of oxidative stress in hypertensive rats. J Am Heart Assoc 2013; 2:e000375.
14. Linz D, Hohl M, Mahfoud F, Reil JC, Linz W, Hübschle T, Juretschke HP, Neumann-Häfin C, Rütten H, Böhm M. Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats. J Transl Med 2012; 10:187.
15. Ernsberger P, Koletsky RJ, Friedman JE. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X. Ann N Y Acad Sci 1999; 892:272-288.
16. Linz D, Wirth K, Linz W, Heuer HO, Frick W, Hofmeister A, Heinelt U, Arndt P, Schwahn U, Böhm M, Ruetten H. Antihypertensive and laxative efects by pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut. Hypertension 2012; 60:1560-1567.
17. Lee VS, Rusinek H, Bokacheva L, Huang AJ, Oesingmann N, Chen Q, Kaur M, Prince K, Song T, Kramer EL, Leonard EF. Renal function measurements from MR renography and a simplifed multicompart-mental model. Am J Physiol Renal Physiol 2007; 292:F1548-F1559.
18. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function afer catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 2012; 60:419-424.
19. Fujii T, Kurata H, Takaoka M, Muraoka T, Fujisawa Y, Shokoji T, Nishiyama A, Abe Y, Matsumura Y. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur J Pharmacol 2003; 481:241-248.
20. Polichnowski AJ, Cowley AW Jr. Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension 2009; 54:1269-1277.
21. Rafq K, Noma T, Fujisawa Y, Ishihara Y, Arai Y, Nabi AH, Suzuki F, Nagai Y, Nakano D, Hitomi H, Kitada K, Urushihara M, Kobori H, Kohno M, Nishiyama A. Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation 2012; 125:1402-1413.
22. Huber TB, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, Pavenstädt H. Catecholamines modulate podocyte function. J Am Soc Nephrol 1998; 9:335-345.
23. Kim J, Padanilam BJ. Renal nerves drive interstitial fbrogenesis in obstructive nephropathy. J Am Soc Nephrol 2013; 24:229-242.
24. Pawluczyk IZ, Patel SR, Harris K P. The role of the alpha-1 adrenoceptor in modulating human mesangial cell matrix production. Nephrol Dial Transplant 2006; 21:2417-2424.
25. Takahashi H, Yoshika M, Komiyama Y, Nishimura M. The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain. Hypertens Res 2011; 34:1147-1160.
26. Roman RJ, Cowley AW Jr. Characterization of a new model for the study of pressure-natriuresis in the rat. Am J Physiol 1985; 248:F190-F198.
27. Gopalakrishnan SM, Chen C, Lokhandwala MF. Alpha 1-adrenocep-tor subtypes mediating stimulation of Na+, K(+)-ATPase activity in rat renal proximal tubules. Eur J Pharmacol 1995; 288:139-147.
28. DiBona GF. Role of the renal nerves in renal sodium retention and edema formation. Trans Am Clin Climatol Assoc 1990; 101:38-44.
29. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The efect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55:845-855.
30. Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, D'Elia L, Russo O, Versiero M, Farinaro E, Cappuccio FP. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 2006; 24:1633-1639.
31. Lohmeier TE, Iliescu R. The sympathetic nervous system in obesity hypertension. Curr Hypertens Rep 15: 409-416.
32. Wolf G, Ziyadeh FN. Leptin and renal fbrosis. Contrib Nephrol 2013; 151:175-183.